Gerrit J Schuurhuis

Gerrit J Schuurhuis

UNVERIFIED PROFILE

Are you Gerrit J Schuurhuis?   Register this Author

Register author
Gerrit J Schuurhuis

Gerrit J Schuurhuis

Publications by authors named "Gerrit J Schuurhuis"

Are you Gerrit J Schuurhuis?   Register this Author

39Publications

993Reads

50Profile Views

Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.

Leuk Res 2019 Jun 9;81:27-34. Epub 2019 Apr 9.

Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, 1081HV Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.04.004DOI Listing
June 2019

Measurable residual disease in acute myeloid leukemia using flow cytometry: approaches for harmonization/standardization.

Expert Rev Hematol 2018 12;11(12):921-935

a Department of Hematology , VU University Medical Center , Amsterdam , Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1549479DOI Listing
December 2018

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

N Engl J Med 2018 Mar;378(13):1189-1199

From the Department of Hematology (M.J.-L., T.G., F.G.K., A.H., A.Z., C.A.J.E.-V., M.A.S., B.L., P.J.M.V.) and HOVON Data Center, Department of Hematology (P.L.G., R.M.), Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, the Department of Hematology, VU University Medical Center (D.H., J.C., G.J.O., G.J.S.), and the Department of Hematology, Academic Medical Center (B.J.B.), Amsterdam, and Isala Hospital, Zwolle (M.M.K.) - all in the Netherlands; UCL Namur (Godinne), Yvoir (C.G.), and the Department of Hematology, Cliniques Universitaires Saint-Luc, Brussels (V.H.) - both in Belgium; and the Department of Hematology, University Hospital Zurich, Zurich (M.G.M.), University Hospital, Bern (T.P.), and the Division of Hematology, University Hospital Basel, Basel (J.R.P.) - all in Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716863DOI Listing
March 2018

The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia.

Cytometry B Clin Cytom 2018 01 15;94(1):151-158. Epub 2017 Aug 15.

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21539DOI Listing
January 2018

Cancer: A gene-expression profile for leukaemia.

Nature 2016 12 7;540(7633):346-348. Epub 2016 Dec 7.

Department of Hematology, Free University Medical Center, De Boelelaan 1117, 1081HV Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature20488DOI Listing
December 2016

CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia.

Br J Haematol 2016 Apr 27;173(2):219-35. Epub 2016 Jan 27.

Department of Haematology, VU University Medical Centre, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13941DOI Listing
April 2016

Absence of leukaemic CD34 cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered.

Br J Haematol 2015 Oct 24;171(2):227-238. Epub 2015 Jun 24.

Department of Haematology, VU University Medical Centre, Cancer Centre Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13572DOI Listing
October 2015

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

J Clin Oncol 2013 Nov 23;31(31):3889-97. Epub 2013 Sep 23.

Monique Terwijn, Angèle Kelder, Peter C. Huijgens, Angelika M. Dräger, Yvonne J.M. Oussoren, Willemijn J. Scholten, Alexander N. Snel, Gert J. Ossenkoppele, and Gerrit J. Schuurhuis, VU University Medical Centre; Bart J. Biemond, Academic Medical Centre, Amsterdam; Wim L.J. van Putten, Vincent H.J. van der Velden, Georgine E. de Greef, Peter J.M. Valk, Mojca Jongen-Lavrecic, and Bob Löwenberg, Erasmus University Medical Centre; Rik A. Brooimans, Jan W. Gratama, Erasmus University Medical Centre/Daniel den Hoed Cancer Centre, Rotterdam; Frank W.M.B. Preijers, Radboud University Nijmegen Medical Center, Nijmegen; Michel van Gelder, University Medical Centre, Maastricht; Pierre Wijermans, Haga Hospital, The Hague; Marie-Cecile Legdeur and Jennita Slomp, Medisch Spectrum Twente, Enschede; Jurgen Kuball, University Medical Center Utrecht; Okke de Weerdt, St. Antonius Hospital, Nieuwegein; Leo F. Verdonck, Isala Clinics, Zwolle, the Netherlands; Thomas Pabst, Bern University Hospital, Bern; Urs Schanz, University Hospital, Zürich; Jakob R. Passweg, Basel University Hospital, Basel; Mario Bargetzi, Kantonspital, Aarau; Yves Chalandon, University Hospital of Geneva, Geneva; Urs Hess, Kantonsspital, St. Gallen, Switzerland; Johan Maertens, University Hospital Gasthuisberg; Nancy Boeckx, University Hospitals Leuven and Katholieke Universiteit Leuven, Leuven; Carlos Graux, Cliniques Universitaires-Université Catholique de Louvain, Mont-Godinne, Yvoir; and Marie-Christiane Vekemans, St. Luc Hospital, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.9628DOI Listing
November 2013

Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.

Curr Pharm Des 2013 ;19(5):940-50

Dept. Medical Oncology, VUmc Cancer Center Amsterdam, VU University Medical Center, CCA room 1.52, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
July 2013

How to assess minimal residual disease in pediatric and adult acute myeloid leukemia?

Transl Pediatr 2013 Apr;2(2):80-3

1 Department of Haematology, 2 Department of Haematology and Pediatric Oncology/Haematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2224-4336.2013.04.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728920PMC
April 2013

Towards cure of CML: why we need to know more about CML stem cells?

Curr Stem Cell Res Ther 2009 Sep;4(3):224-36

Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
September 2009

Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.

Cytometry B Clin Cytom 2008 Jan;74(1):9-16

Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.20375DOI Listing
January 2008

Activated intrinsic apoptosis pathway is a key related prognostic parameter in acute myeloid leukemia.

J Clin Oncol 2007 Apr;25(10):1209-15

Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.08.4061DOI Listing
April 2007

Flow cytometric evaluation of PI3K/Akt and MAPK/ERK activation.

Haematologica 2006 Jun;91(6):723B

Department of Hematology, VU University Medical Center, Amsterdam,The Netherlands.

View Article

Download full-text PDF

Source
June 2006

Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis.

Clin Cancer Res 2005 Apr;11(7):2540-6

Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-1973DOI Listing
April 2005

Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells.

Haematologica 2003 Sep;88(9):983-93

Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
September 2003

Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.

Haematologica 2003 May;88(5):497-508

Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
May 2003